Pathology Flashcards
Cell adaptation
- hypertrophy
- hyperplasia
- atrophy
- metaplasia
- dysplasia
- increase in structural proteins and organelle which increases size of cell
- controlled proliferation of stem cells -> increase in amnt of cells
- decrease in tissue mass because decrease in size or number of cells
- reprogramming of stem cells causing replacement of one cell type to another because it is better at adapting to certain stressor
- disordered precancerous epi cell growth characterized by loss of uniformity of cell size and shape
Injury
- reversible: ATP, ribosomes, membrane, nuclear, function
- irreversible: membrane, mito, lysosome, nuclear
- decrease in ATP -> decrease Ca activity and Na/K pmp -> cellular swelling; ribosomal detachment -> decrease protein synthesis; plasma membrane changes; nuclear changes; rapid loss of function
- breakdown of plasma membrane -> Ca into cell -> activates proteases; mito damage dysfunction -> loss of ETC -> low ATP; rupture of lysosomes -> autolysis; nuclear degradation
Apoptosis
- intrinsic: what is it, regulated by, Function of apoptotic, Function of anti-apoptotic
- extrinsic: 2 pathways
- regulating factor is withdrawn from proliferating cell causing apoptosis; BCL2 family, BAX and BAK: form pores into mito membrane -> release of cyto C from inner mito membrane to cytoplasm -> activation of capases; BCL2: keep mito membrane impermeable
- ligand binding receptor (Fas-FasL or TNF-alpha) or immune cell mediated (CD8+ or NK)
Types of Necrosis
- coagulative: seen in, due to, histo
- liquefactive
- caseous
- fat
- fibrinoid
- gangrenous
- ischemia / infarct; injury that denatures proteins; preserved cell architecture but nuclei disappear
- bacterial abcesses or brain infarcts; PMN release lysosomal enzymes that digest tissue; cellular debris and macro -> cystic spaces and cavitations
- TB, systemic fungi; macro wall off infecting organism -> granular debris; fragmented cells and debris surrounded by lymphocytes
- enzymatic: acute pancreatitis, non-enzymatic: trauma; damaged pancreatic cells release lipase which breaks down trigly and FFA binds to CA -> causing chalk white appearance of fat; outline of dead fat cell w/o peripheral nuclei
- immune vascular reaction; immune complex deposition and or plasma protein leakage from damaged vessel; vessel walls are thick and pink
- distal extremity and GI tract after chronic ischemia; Dry: ischemia, wet: super-infection; coagulative or liquefactive on top of coagulative
Ischemia
- what is it
- mechanism
- inadequate blood supply to meet demand
- decrease arterial perfusion, decreased venous drainage, shock
Type of infarct
- red
- white
- occurs in venous occlusions and tissues w/ multiple blood supplies and with re-perfusion
- occurs in solid organ with single blood supply
Free radical injury
- function
- caused by
- damage cell membrane by lipid peroxidation
- radiation, meds, redox reactions, NO
- scavenging enzymes, spontaneous decay, anti-oxidant
Type of calcification
- dystrophic: cell type, extent, etiology, serum Ca levels, associated conditions
- metastatic: cell type, extent, etiology, serum Ca levels, associated conditions
- in diseased tissue; localized; secondary to injury or necrosis; normal; TB, chronic abcess, fat necrosis, infarct
- in normal tissue; widespread; secondary to hyper Ca; abnormal; in interstitum of kidney, lung, GI mucosa,
Lipofuscin
- what is it
- cause
- found in
- yellow-brown wear and tear pigment associated w/ normal aging
- oxidation and polymerization og autophagocytosed organellar membranes
- heart, colon, liver, kidney, eye of elederly on autopsy
Amyloidosis
- what is it/ pathogenesis
- visualized w/
- location
- abnormal aggregation of proteins into beta pleated linear sheets -> insoluble fibrils -> cell damage and apoptosis
- congo-red stain
- glomerular mesangial areas
Systemic amyloidosis
- primary: fibril protein, seen in
- secondary
- dialysis
- AL protein, seen in plasma cell disorders
- serum amyloid A, seen in chronic inflamm conditions
- B2 microglobulin, seen in pts with ESRD
Localized amyloidosis
- Alzheimers: protein, from
- Type II DM: protein, cause
- Medullary thyroid CA: protein
- Isolated atrial amyloidosis: protein, pathogenesis, risk
- systemic senile amyloidosis: protein, location
- Beta amyloid protein; cleaved from amyloid precursor protein
- Islet amyloid polypeptide; caused by deposition of amylin in pancreatic islet cells
- calcitonin
- ANP, common in normal aging but puts at risk for a fib
- transthyretin, seen predominantly in cardiac ventricles
Hereditary amyloidosis
- familial amyloid cardiomyopathy: protein, location, causes
- familial amyloid polyneuropathy: protein
- mutated transthyretin, ventricular endocardium -> restrictive cardiomyopathy
- mutated transthyretin -> caused by tranthyretin gene mutation
Inflammation
- what is it
- signs
- acute phase
- fever
- response to eliminate cause of cell injury, remove necrotic cells and initiate tissue repair
- erythema / heat (histamine/ prostaglandin/ bradykinin causing increase in vasodilation), tumor / swelling (leukotrienes, hitamine, serotonin causeeing endothelial disruption allowing for leakage of proteins and increasing interstial oncotic pressure), pain (bradykinin, PGE2, histamine causing sensitization of nerve endings), loss of function
- fever, leukocytosis, increase in plasma acute phase protein produced by liver
- pyrogens cause macro to release IL-1 and TNF -> increase COX -> in pervacsular cells in hypothal -> increase PGE2 -> increase set point
- elevation of WBC count and type of cell depends on inciting agent
Acute phase reactants
- ferritin
- fibrinogen
- serum amyloid A
- hepcidin
- CRP
- albumin
- transferrin
- upreg, binds and sequesters iron to inhibit microbial iron scavenging
- upreg, coag factor, promotes endo repain, correlates with ESR
- upreg, prolonged leads to amyloidosis
- upreg, decrease iron absorption and release
- upreg, opsonin
- down reg, conserves AA
- down reg, internalized by macrophages to sequester iron
Erythrocyte sedimentation rate
- what is it
- RBC normally able to remain separated by neg charge but with inflammation fibrinogen will coat RBC and decrese negative charge -> increase in RBC aggregation
Exudate vs Transudate
- exudate: cell, protein, caused by
- transudate
- light criteria
- cellular (cloudy), high protein, lymph obstruction/ inflammation/ infection/ malignancy
- hypocellular (clear), low protein, increase in hydrostatic pressure or decrease in oncotic pressure
- pleural fluid is exudative if more than 1 of following criteria is met: has fluid/serum protein ration > 0.5, fluid/serum LDH ration > .6, pleural fluid LDH > 2/3 of upper limit of normal serum LDH
Acute inflammation
- what is it
- characterized by
- stimuli
- mediators
- vascular component
- cellular component
- outcomes
- transient and early response to injury or infection
- PMNs in tissue and edema
- infection, trauma, necrosis, foreign bodies
- TLR, arachadonic acid metabolites, PMN, eosinophil
- vasodilation and increase in endothelial permeability
- extravasion of leukocytes from post-cap venules and accumulation in location of injury
- resolution and healing, abcess, scarring
Leukocyte extravasion
- margination and rolling: endo cells express, leukocytes express
- tight binding: endo cells express, leukocytes express
- diapedesis: what is it, endo cells express, leukocytes express
- migration: what is it, endo cells express, leukocytes express
- endo: E-selectin, P-selecting, GlyCAM1; Leuko: Sialyl lewis and L-selectin; leukocyte adhesion deficiency type 2 bs of decrease in sialyl lewis
- endo: ICAM and VCAM; Leukocyte: CD11/12 and VLA4; defective in leukoocyte adhesion deificiency type 1
- WBC travel between endo cell and exits blood vessel; PECAM-1 (both endo and leuko)
- WBC travels in interstitium to site of injury or infection guided by chemotactic signal; endo: C5a, IL8
Wound healing tissue mediators
- FGF
- TGF beta
- VEGF
- PDGF
- Metalloproteinases
- EGF
- stimulates angiogenesis
- angiogenesis and fibrosis
- stimulate angiogenesis
- secreted by platelets, induces vascular remodeling and smooth muscle cell migration, stimulates fibroblast growth for collagen synthesis
- tissue remodeling
- stimulates cell growth via tyrosine kinase
Phase of wound healing
- inflammatory
- proliferative
- remodeling
- immediate to 3 days after wound; pleatelets, PMN, macro; clot formation, increase vessel permeability and PMN migration into tissue, macro clear debris 2 days later
- 3 days to weeks after wound; fibroblasts, myofibrblasts, endothelial cells, keratinocytes, macro; deposition of granulation tissue and type III collagen, angiogenesis, epi cell proliferation, dissolution of clot and wound contraction
- 1 week to 6 month; fibroblasts; type III colagen replaced by type I collagen to increase tensile strength of tissue, collagenases, zinc deficiency
Phase of wound healing
- inflammatory: time frame, cells involved, characteristics
- proliferative: time frame, cells involved, characteristics
- remodeling: time frame, cells involved, characteristics
- immediate to 3 days after wound; pleatelets, PMN, macro; clot formation, increase vessel permeability and PMN migration into tissue, macro clear debris 2 days later
- 3 days to weeks after wound; fibroblasts, myofibrblasts, endothelial cells, keratinocytes, macro; deposition of granulation tissue and type III collagen, angiogenesis, epi cell proliferation, dissolution of clot and wound contraction
- 1 week to 6 month; fibroblasts; type III colagen replaced by type I collagen to increase tensile strength of tissue, collagenases, zinc deficiency
Granulomatous inflammation
- what is it
- caused by
- used for
- histo
- types
- mechanism
- anti TNF
- pattern of chronic inflammation
- by persistent T-cell response to certain infections
- wall off a resistant stimulus w/o completely eradicating or degrading it
- activated macrophage w/ abundant pink cytoplasm surrounded by lymphocytes lymphocytes and giant cells
- caseating w/ central necrosis or non caseating w/o necrosis
- APC present antigens to CD4 helper T cells and secrete IL-2 -> differentiate into Th1 cells -> secrete INF gamma -> macrophages activated -> macrophage increase cytokine secretion -> formation of giant cells
- cause sequestering granulomas to break down -> disseminated disease
Scar formation
- what?
- hypertrophic
- keloid
- occurs when repair cannot be accomplished by cell regeneration, non-regenerated cells replaced by CT
- increased type III collagen, collagen is parallel, scar confined to to borders of original wound, infrequent recurrence and no predispostion
- very high type I and III collagen, disorganized collagen organization, extends beyond border of original would with claw like projections typically on earlobes, face, UE, frequently recur, increase incidence in ethnic groups w/ darker skin
Neoplasia
- what is it
- components
- dysplasia
- carcinoma in situ
- invasive carcinoma
- mets
- uncontrolled, monoclonal proliferation of cells, can be malignant or benign
- parenchyma (neoplastic cells) and supporting stroma (blood vessels, CT)
- loss of uniformity in cell size and shape, loss of tissue orientation, nuclear changes
- irreversible severe dysplasia that involves the entire thickness of epi but the basement membrane is intact
- cells have invaded the basement membrane using collagenases and hydrolases, cell-cell contacts lost bu inactivation of E-cadherin
- spread to distant organs via lymphatics or blood
Tumor nomenclature
- carcinoma
- sarcoma
- benign
- malignant
- hamartoma
- choriostoma
- epthelial origin
- mesenchymal origin
- well differentiated and wll demarcated, low mitotic activity, no mets, no necrosis
- poor diferentiation, erratic growth, local invasion, mets, decreased apoptosis
- disorganized growth of tissue in native location
- normal tissue in foreign location
Cell type and types of CA
- Epi: benign, malignant
- blood cells: malignant
- blood vessels: benign, malignant
- SM: benign, malignant
- Striated muscle: benign, malignant
- CT: benign, malignant
- Bone: benign, malignant
- Fat: benign, malignant
- Melanocyte: benign, malignant
- adenoma, papilloma; adenocarcinoma, papillary carcinoma
- leukemia, lymphoma
- hemangioma; angiosarcoma
- leiomyoma; leiomyosarcoma
- rhabdomyoma; rhabdomyosarcoma
- fibroma; fibrosarcoma
- osteoma; osteosarcoma
- lipoma; liposarcoma
- nevus; melanoma
Tumor grade vs Stage
- grade
- stage
- degree of cellular differentiation (how much it looks like tissue of origin) on histo
- degree of localization/ spread based on site and size of primary location, spread to regional LN, presence of mets; determines survival
Immune evasion in CA
- what happens
- escape mechanisms
- immune cells can recognize and attack tumor cells
- decreased MHC class I expression -> cytotoxic T cells unable to recognize tumor cells, secrete immunosuppressive factors, up-reg immune chekpoint mutations
Common Mets
- sarcoma
- carcinoma
- four carcinoma route hemato
- hematogenously
- lymph
- follicular thyroid, choriocarcinoma, renal cell, and heptaocellular
Oncogenic Microbes
- EBV
- HBV, HCV
- HHV-8
- HPV
- H pylori
- HTLV-1
- Liver fluke
- Schistosoma
- Burkitt lymphoma
- Heptaocellular carcinoma
- Kaposi sarcoma
- Cervical and penile/anal carcinoma, head and neck CA
- gastric adenocarcinoma and MALT lymphoma
- adult t-cell leukemia
- cholangiocarcinoma
- squamous cell bladder CA
Serum tumor marker
- alk phos
- alpha fetoprotein
- hCG
- CA-15/ CA 27-29
- CA 19-9
- CA 125
- Calcitonin
- CEA
- chromogranin
- LDH
- Neuron specific enolase
- PSA
- mets to bone or liver, pagets dx, seminoma
- hepatocellular carcinoma, mixed germ cell tumor, neural tube defects
- hydatidiform mole and choriocarcinoma
- breast CA
- pancreatic adenocarcinoma
- ovarian carcinoma
- medullary thyroid carcinoma
- colorectal and pancreatic carcinoma
- neuroendocrine tumor
- testicular germ cell tumors, ovarian dysgerminoma
- neuroendocrine tumor
- prostate CA
IHC stains
- chromogranin
- cytokeratin
- desmin
- GFAP
- neurofilament
- s-100
- TRAP
- neuroendocrine cells -> small cell carcinoma of lung
- epithelial cells
- muscle
- neuroglia -> astrocytoma, glioblastoma
- neurons
- neural crest cells
- hair cell leukemia
P- glycoprotein
- in
- for
- in adrenocortical carcinoma
- used to pump out toxins including chemo agents
Psammoma bodies
- histo
- which cancers
- laminated, concentric spherules w/ dystrophic calcification
- papillary carcinoma of thyroid, somatostatinoma, meningioma, mesothelioma, ovarian serous papillary cystadenocarcinoma, prolactinma
Cachexia
- what is it
- caused by
- weight loss, muscle atrophy, and fatigue that occurs w/ chronic dx
- TNF alpha, IFN gamma, IL-1 and 6
Paraneoplastic Syndrome MS and cutaneous
- dermatomyositis: description/ mechanism; most common tumor
- acanthosis nigricans
- sign of leser-trelat
- hypertrophic osteoathropathy
- progressive proximal muscle waekness, gottron papules, heliotrope rash
- hyperpigmented velvety plaques in axilla and neck
- sudden onset of mult seborrheic keratoses
- abnrml proliferation of skin and bone at distal extremities
Paraneoplastic Syndrome endocrine
- hypercalcemia: description/ mechanism; most common tumor
- cushing syndrome
- hyponatremia
- PTHrP; suamous cell carcinoma of lung, head, and neck
- high ACTH, small cell lung CA
- High ADH, small cell lung CA
Paraneoplastic Syndrome hematologic
- polycythemia: description/ mechanism; most common tumor
- pure red cell plasia
- good syndrome
- trosseau syndrome
- nonbacterial throbmotic endocarditis
- increased erythropoietin; pheochromocytoma, renal cell carcinoma
- anemia w/ low reticulocytes; thymoma
- hypogammaglobulinemia; thymoma
- migratory superficial thrombophlebitis; adenocarcinoma
- deposition of sterile platelet thrombi on heart valves; adenocarcinoma
Paraneoplastic Syndrome Neuromuscular
- anti NMDA receptor encephalitis: description/ mechanism; most common tumor
- opsoclonus-myoclonus ataxia syndrome
- paraneoplastic cerebellar degeneration
- paraneoplastic encephalomyelitis
- lamber-eatn myasthenic syndrome
- myasthenia gravis
- psych disturbances, memory deficits, seizures; ovarian teratoma
- dancing eyes and feet; neuroblastoma and small cell lung
- antibodies against purkinje cells; small cell, gycenologic and breast CA
- antibodies against Hu antigen in neuron; small cell lung CA
- antibodies against pre-synaptic channels at NMJ; small cell lung CA
- antibodies against postsynaptic Ach receptors at NMJ; thymoma